-Review the quality of english language.
-The introduction section is insufficient and needs to be expanded; I suggest to the authors to add an overview on the other therapeutic approaches for osa. Recent studies report the effectiveness of mandibular advancement for the treatment of respiratory disorders, for example: "Orthopaedics treatment effects of functional therapy on the sagittal pharyngeal dimensions in subjects with Sleep-disordered Breathing and Class II malocclusion". Pavoni C, Cretella Lombardo E, Lione R, Bollero P, Ottaviani F, Cozza P. Acta Otorhinolaryngol Ital. 2017 Dec;37(6):479-485"; "Treatment and post-treatment effects of functional therapy on the sagittal pharyngeal dimensions in Class II subjects". Pavoni C, Cretella Lombardo E, Franchi L, Lione R, Cozza P. Int J Pediatr Otorhinolaryngol. 2017 Oct;101:47-50".
-Bibliography needs to be updated. I recommend to the authors to insert in the references list the mentioned above articles. 
GENERAL COMMENTS
1. Is the research question or study objective clearly defined? NO The authors state that "The aim of this systematic review is to comprehensively review the literature and synthesise relevant data to determine the effects of AT on the growth of children with OSAHS." a. Please consider keeping succinct the main objective: "The main objective of this review is to assess the effects of AT on the growth of children with OSAHS." b. The authors consider "AT related adverse events" as a secondary outcome. I suggest that you describe this as a secondary objective as well: "The secondary objective of this review is to determine AT related adverse effects in children with OSAHS."
3. Is the study design appropriate to answer the research question? NO a. The authors should justify why non-randomised designs are eligible for this review. b. I suggest that eligibility criteria emphasise specific features of study design (e.g. which parts of the study were prospectively designed) rather than 'labels' for study designs (such as prospective cohort studies). See examples in http://handbook-5-1.cochrane.org/chapter_13/13_2_2_guidance_and_resources_ava ilable_to_support_review.htm c. I suggest that authors detail if they will combine randomised and non-randomised studies in the same meta-analysis (which is usually discouraged). d. "For prospective cohort studies, healthy subjects (with age under 18 but without OSAHS) in a concurrent control group will also be considered." I recommend against including studies with healthy subjects, that is, without OSAHS, as these participants do not meet the review inclusion criteria (children with a diagnosis of OSAHS). 12. Are the study limitations discussed adequately? NO a. The authors should highlight that the potential for bias is likely to be greater for non-randomized studies compared with randomised trials.
VERSION 1 -AUTHOR RESPONSE
Response to Reviewers bmjopen-2019-030866
Comments from Reviewer #1:
1. Review the quality of English language.
Response: Thank you for your comments. We have checked the manuscript and revised it to improve its language quality.
2. The introduction section is insufficient and needs to be expanded; I suggest to the authors to add an overview on the other therapeutic approaches for osa. Recent studies report the effectiveness of mandibular advancement for the treatment of respiratory disorders, for example: "Orthopaedics treatment effects of functional therapy on the sagittal pharyngeal dimensions in subjects with Sleepdisordered Breathing and Class II malocclusion". Pavoni C, Cretella Lombardo E, Lione R, Bollero P, Ottaviani F, Cozza P. Acta Otorhinolaryngol Ital. 2017 Dec;37(6):479-485"; "Treatment and posttreatment effects of functional therapy on the sagittal pharyngeal dimensions in Class II subjects". Pavoni C, Cretella Lombardo E, Franchi L, Lione R, Cozza P. Int J Pediatr Otorhinolaryngol. 2017 Oct;101:47-50".
Response: Thank you. We have added a sentence in the 'description of the intervention' section, referring to these articles that you have recommended.
3. Bibliography needs to be updated. I recommend to the authors to insert in the references list the mentioned above articles.
Response: Thank you. We have replaced the previous references #2, #3, and #5 with more recent articles. We have also added the articles that you have recommended into the reference list.
Comments from Reviewer #2:
4. Is the research question or study objective clearly defined? NO
The authors state that "The aim of this systematic review is to comprehensively review the literature and synthesise relevant data to determine the effects of AT on the growth of children with OSAHS." a. Please consider keeping succinct the main objective:
"The main objective of this review is to assess the effects of AT on the growth of children with OSAHS."
Response: Thank you very much for your comments. Revision done.
b. The authors consider "AT related adverse events" as a secondary outcome. I suggest that you describe this as a secondary objective as well:
"The secondary objective of this review is to determine AT related adverse effects in children with OSAHS."
Response: Thank you very much.
1) We agree that it will be ideal to look at both benefits and harms at the same time, but after thorough consideration, we believe it is very difficult (if not impossible) to include all the benefits and harms of AT in a single systematic review.
2) In effect, there are many AT related complications and they have been summarized by recent systematic reviews specifically on this topic.1
3) Plus, our search strategy was designed to identify all relevant literature related to AT and growth, which means that it is not sensitive enough to identify all articles regarding harms of AT.
4) Therefore, we have deleted 'AT related adverse events' from our list of outcome measures.
2. Is the study design appropriate to answer the research question? NO a. The authors should justify why non-randomised designs are eligible for this review.
Response: As shown in a recent article regarding AT and craniofacial development, most of the relevant studies were observational.2 The main reason behind this is that it will be unethical to randomise children with OSAHS to a control group (without treatment). In addition, although RCTs are the gold standard to evaluate the effectiveness of interventions, prospective cohort can also provide valuable information and real-world evidence.
b. I suggest that eligibility criteria emphasise specific features of study design (e.g. which parts of the study were prospectively designed) rather than 'labels' for study designs (such as prospective cohort studies c. I suggest that authors detail if they will combine randomised and non-randomised studies in the same meta-analysis (which is usually discouraged).
Response: We have added one sentence to the data synthesis section to emphasize that data from RCTs and those from cohort studies will not be combined in any meta-analysis. As stated previously, we plan to explore the influence of study design (e.g. RCTs vs. cohort studies) in a subgroup analysis.
d. "For prospective cohort studies, healthy subjects (with age under 18 but without OSAHS) in a concurrent control group will also be considered."
I recommend against including studies with healthy subjects, that is, without OSAHS, as these participants do not meet the review inclusion criteria (children with a diagnosis of OSAHS).
Response: Thank you very much. We have removed healthy subjects from the 'types of participants' section. 1. We agree that statistical significance and clinical significance are different, and that the use of minimum clinically important difference (MCID) will be beneficial for interpreting results of our systematic review. However, we have failed to find from the literature any commonly accepted MCID for each of our outcome measures, in the context of our research question. This may be due to the low quantity of studies regarding this research question, and the fact that different studies have adopted different study design, outcome measure, source of samples (e.g. geographical location, age range), length of follow-up and methods to calculate an appropriate sample size. 4,5 We have added one sentence to the Article Summary table to reflect this limitation.
2. The lack of standard / agreed MCID is relatively common across medical areas.6 Therefore, the PRISMA guideline does not require the reporting of MCIDs. 7
3. However, we will consider the clinical significance of our findings in our assessment of evidence certainty using the standard GRADE approach, which is also a recommended and method to interpret clinical significance.7,8
e. "Growth related biomarker concentration or concentration Z score" I suggest that you define the biomarker/s that you will consider.
Response: Revision done.
f. Explain how you will address multiple variants of outcome measures (e.g. definitions, scales, time points). For example, will you combine the height measured at one year with the height measured at six months? 
GENERAL COMMENTS
2. Is the study design appropriate to answer the research question? a. The authors should justify why non-randomised designs are eligible Thank you for introducing the paragraph: "According to the Cochrane Handbook, in this review, prospective cohort studies should include two or more groups of participants receiving different intervention. At the same time, their identification of participants, assessment of baseline and allocation to intervention, assessment of outcomes, as well as the generation of hypotheses should be prospective.27" First, I would propose to rewrite the sentence as now it seems to affirm that the Cochrane Handbook states that cohort studies should have two arms. However, chapter 13 of the Cochrane Handbook highlights that when including non-randomised studies in a review a clear description of the eligibility criteria should be provided, instead of providing just the 'study design labels'. The following sentence may reflect this: "For a prospective cohort study to be eligible in the review it should meet the following criteria: 1) it should include two or more groups of participants; 2) the identification of participants, the assessment of baseline, the allocation to intervention, and the assessment of outcomes should be done prospectively. We will not require that the study hypothesis was generated prospectively as this aspect is generally poorly reported. 4. Are the methods described sufficiently to allow the study to be repeated? Table 1 : Search strategy I would propose to revise the search strategy as some aspects may be incorrect: 1)
Step #5, which correctly reflects the concept "Tonsillectomy", is not considered in step #16 2)
Step #16 is not complete as it should include #11 as well: #10 AND (#11 OR #12 OR #13) AND (#14 OR #15) Thus, I propose that #10 should read as follows: #5 AND #10 AND (#11 OR #12 OR #13) AND (#14 OR #15)
Also, if possible, I would propose to delete steps #14 and #15 from the search strategy: if they are maintained, eligible studies that did not contain these terms in the title or abstract will be lost.
VERSION 2 -AUTHOR RESPONSE
Response to Reviewers bmjopen-2019-030866.R1
2. Is the study design appropriate to answer the research question?
a. The authors should justify why non-randomised designs are eligible for this review.
Thank you for introducing the paragraph: "According to the Cochrane Handbook, in this review, prospective cohort studies should include two or more groups of participants receiving different intervention. At the same time, their identification of participants, assessment of baseline and allocation to intervention, assessment of outcomes, as well as the generation of hypotheses should be prospective.27" First, I would propose to rewrite the sentence as now it seems to affirm that the Cochrane Handbook states that cohort studies should have two arms. However, chapter 13 of the Cochrane Handbook highlights that when including non-randomised studies in a review a clear description of the eligibility criteria should be provided, instead of providing just the 'study design labels'. The following sentence may reflect this: "For a prospective cohort study to be eligible in the review it should meet the following criteria: 1) it should include two or more groups of participants; 2) the identification of participants, the assessment of baseline, the allocation to intervention, and the assessment of outcomes should be done prospectively. We will not require that the study hypothesis was generated prospectively as this aspect is generally poorly reported. Response: Thank you very much for your comments! We have revised the sentence and added the reference according to your suggestion.
4. Are the methods described sufficiently to allow the study to be repeated? Table 1 : Search strategy I would propose to revise the search strategy as some aspects may be incorrect:
Step #5, which correctly reflects the concept "Tonsillectomy", is not considered in step #16
2)
Step #16 is not complete as it should include #11 as well: #10 AND (#12 OR #13) AND (#14 OR #15) Thus, I propose that #10 should read as follows: #5 AND #10 AND (#11 OR #12 OR #13) AND (#14 OR #15) Also, if possible, I would propose to delete steps #14 and #15 from the search strategy: if they are maintained, eligible studies that did not contain these terms in the title or abstract will be lost.
Response: Thank you very much. We have corrected those mistakes and deleted steps #14 and #15.
